Abstract

During development, pyramidal neurons undergo dynamic regulation of AMPA receptor (AMPAR) subunit composition and density to help drive synaptic plasticity and maturation. These normal developmental changes in AMPARs are particularly vulnerable to risk factors for Autism Spectrum Disorders (ASDs), which include loss or mutations of synaptic proteins and environmental insults, such as dietary zinc deficiency. Here, we show how Shank2 and Shank3 mediate a zinc-dependent regulation of AMPAR function and subunit switch from GluA2-lacking to GluA2-containing AMPARs. Over development, we found a concomitant increase in Shank2 and Shank3 with GluA2 at synapses, implicating these molecules as potential players in AMPAR maturation. Since Shank activation and function require zinc, we next studied whether neuronal activity regulated postsynaptic zinc at glutamatergic synapses. Zinc was found to increase transiently and reversibly with neuronal depolarization at synapses, which could affect Shank and AMPAR localization and activity. Elevated zinc induced multiple functional changes in AMPAR, indicative of a subunit switch. Specifically, zinc lengthened the decay time of AMPAR-mediated synaptic currents and reduced their inward rectification in young hippocampal neurons. Mechanistically, both Shank2 and Shank3 were necessary for the zinc-sensitive enhancement of AMPAR-mediated synaptic transmission and act in concert to promote removal of GluA1 while enhancing recruitment of GluA2 at pre-existing Shank puncta. These findings highlight a cooperative local dynamic regulation of AMPAR subunit switch controlled by zinc signaling through Shank2 and Shank3 to shape the biophysical properties of developing glutamatergic synapses. Given the zinc sensitivity of young neurons and its dependence on Shank2 and Shank3, genetic mutations and/or environmental insults during early development could impair synaptic maturation and circuit formation that underlie ASD etiology.

Highlights

  • Autism Spectrum Disorders (ASDs) have symptom onset during the first three years of life, a period characterized by intense formation and refinement of synaptic connections

  • Shank2 and Shank3 showed strong colocalization (Figure 1E) at DIV 11 (78.14 ± 2.43%) that remained stable through these developmental stages (DIV 18, 77.23 ± 2.58%), implying that both proteins might function in concert at the same synapses

  • The dynamic regulation of neurotransmitter receptor number and composition is a fundamental mechanism underlying synaptic plasticity, synaptic maturation and neural circuit development (Henley et al, 2011; Bassani et al, 2013; Henley and Wilkinson, 2016). This regulation is critical for the encoding of information, cognition and behavior and is vulnerable to genetic and environmental insults associated with ASD (Shepherd and Huganir, 2007; Lee et al, 2016; Kim et al, 2018)

Read more

Summary

Introduction

Autism Spectrum Disorders (ASDs) have symptom onset during the first three years of life, a period characterized by intense formation and refinement of synaptic connections. Shank is thought to play a key role in growth cone function and nascent synapse formation (Du et al, 1998; Bresler et al, 2004) and Shank for dendritic spine morphogenesis (Roussignol et al, 2005). Both Shank and Shank knockout mice show impairments of synaptic plasticity and learning These data support the important roles of Shank and Shank in synapse formation and plasticity

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call